SIRT6 and Obesity: Overall, overweight and obesity are marked by disruptions in glucose metabolism such as insulin resistance and hyperglycemia, and could potentially be exacerbated by the absence of Sirt6 that leads to an expansion of ISCs and TICs, thereby increasing the risk of adenoma development and colorectal cancer.